COVID-19 Vaccine Information

You cannot receive your COVID-19 vaccine at the Chester County Health Department if you are experiencing COVID-19 symptoms OR you have been exposed to COVID-19 within 10 days of your appointment. Please reschedule your appointment using the “Change/Cancel Appointment” button in your confirmation and reminder emails. Walk-in appointments are unavailable at this time.

You must wear a mask to your appointment. Vaccine clinics are considered healthcare settings, therefore masks are required to enter clinic buildings.

What's New?
Booster and 3rd Dose Guidance
Schedule a Vaccine Appointment
Safety Information
Replace My Vaccine Card

The Chester County Health Department has received a supply of Novavax COVID-19 doses and appointments are now available. The Novavax vaccine is a more traditional, protein-based vaccine, which has been widely used for decades. The 2-dose vaccine is administered 3 to 4 weeks apart. It is ONLY approved for adults who have NEVER had any COVID-19 vaccine. While Novavax has applied for use as a booster, it has not been approved yet. Booster approval my come in the Fall.
The White House is working toward allowing second COVID-19 boosters for all adults. We must first receive approval from the CDC and FDA before we can start administering second boosters to everyone. We will post on social media and the website once we have these approvals.
The CDC approved COVID-19 vaccines for children 6 months and older. Click here to schedule an appointment.
Walk-in appointments are unavailable at this time.
Booster Eligibility: Children ages 5-11 are now eligible for a Pfizer booster. This booster must be scheduled at LEAST 5 months from Dose 2 (to the day). Please choose the “Booster 5-11 year olds Pfizer” when making an appointment with the Health Department.

Stay Up to Date with Your Vaccines

Up to date means a person has received all recommended COVID-19 vaccines, including any booster dose(s) when eligible
Fully vaccinated means a person has received their primary series of COVID-19 vaccines
Pfizer and Moderna Primary Series: An 8-week interval between dose 1 and dose 2 may be optimal for some people ages 12 and older, especially for males ages 12 - 39 years.
- A shorter interval (3 weeks for Pfizer-BioNTech; 4 weeks for Moderna) between the 1st and 2nd doses remains the recommended interval for: people who are moderately or severely immunocompromised; adults ages 65 years and older; and others who need rapid protection due to increased concern about community transmission or risk of severe disease.